SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Symphony Capital Partners LP

(Last) (First) (Middle)
C/O SYMPHONY CAPITAL PARTNERS, L.P.
875 THIRD AVENUE, 18TH FLOOR

(Street)
NEW YORK NY 10022

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
OXIGENE INC [ OXGN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
Officer (give title below) X Other (specify below)
See Footnote 3 and Remarks
3. Date of Earliest Transaction (Month/Day/Year)
12/30/2008
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/30/2008 X(1) 11,281,877 A $1.11 17,117,118 I See Footnotes(2)(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Common Stock Warrant (right to buy) $1.11 12/30/2008 X(1) 11,281,877 (4) 10/17/2018 Common Stock 11,281,877 $0 0 I See Footnotes(1)(3)
1. Name and Address of Reporting Person*
Symphony Capital Partners LP

(Last) (First) (Middle)
C/O SYMPHONY CAPITAL PARTNERS, L.P.
875 THIRD AVENUE, 18TH FLOOR

(Street)
NEW YORK NY 10022

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
X Director X 10% Owner
Officer (give title below) X Other (specify below)
See Footnote 3 and Remarks
1. Name and Address of Reporting Person*
SYMPHONY CAPITAL GP, L.P.

(Last) (First) (Middle)
875 THIRD AVENUE
18TH FLOOR

(Street)
NEW YORK NY 10022

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
X Director X 10% Owner
Officer (give title below) X Other (specify below)
See Footnote 3 and Remarks
1. Name and Address of Reporting Person*
SYMPHONY GP, LLC

(Last) (First) (Middle)
875 THIRD AVENUE
18TH FLOOR

(Street)
NEW YORK NY 10022

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
X Director X 10% Owner
Officer (give title below) X Other (specify below)
See Footnote 3 and Remarks
1. Name and Address of Reporting Person*
SYMPHONY ViDA HOLDINGS LLC

(Last) (First) (Middle)
875 THIRD AVENUE
18TH FLOOR

(Street)
NEW YORK NY 10022

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
X Director X 10% Owner
Officer (give title below) X Other (specify below)
See Footnote 3 and Remarks
1. Name and Address of Reporting Person*
TARANTO HARRI V

(Last) (First) (Middle)
C/O SYMPHONY CAPITAL PARTNERS, L.P.
875 THIRD AVENUE, 18TH FLOOR

(Street)
NEW YORK NY 10022

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
X Director X 10% Owner
Officer (give title below) X Other (specify below)
See Footnote 3 and Remarks
Explanation of Responses:
1. In accordance with the terms of the Stock and Warrant Purchase Agreement (the "SWPA") entered into between Symphony ViDA Holdings LLC ("Holdings") and OXiGENE, Inc. (the "Issuer") on October 1, 2008, Holdings exercised a warrant to purchase 11,281,877 shares of common stock of the Issuer (the "Warrant") on December 30, 2008.
2. Includes 17,117,118 shares of common stock directly owned by Holdings.
3. Symphony Capital Partners, L.P. ("SCP L.P.") is the manager of Holdings; Symphony GP, LLC ("SGP LLC") is the general partner of Symphony Capital GP, L.P. ("SC GP L.P."), which is the general partner of SCP L.P. (collectively, the "Symphony Entities"). Mark Kessel and Harri V. Taranto are managing members of SGP LLC. Mr. Kessel, Mr. Taranto and the Symphony Entities are referred to as the "Reporting Persons." Mr. Kessel is also a member of the Issuer's board of directors. As such, the Reporting Persons other than Mr. Kessel may be deemed to be a director of the Issuer by deputization.
4. Pursuant to the SWPA, Holdings could not exercise the Warrant (subject to limited exceptions) until the Issuer's stockholders approved the issuance and sale of the common stock underlying the Warrant. On December 9, 2008, the Issuer held a special meeting of its stockholders and obtained the requisite stockholder approval for the issuance.
Remarks:
The reporting persons may be deemed to be a member of a "group" for purposes of the Securities Exchange Act of 1934, as amended. The reporting persons disclaim beneficial ownership of any securities deemed to be owned by the group that are not directly owned by such reporting persons. This report shall not be deemed an admission that any reporting person is a member of a group or the beneficial owner of any securities not directly owned by the reporting persons.
/s/ Mark Kessel 08/12/2009
/s/ Mark Kessel 08/12/2009
/s/ Mark Kessel 08/12/2009
/s/ Mark Kessel 08/12/2009
/s/ Harri V. Taranto 08/12/2009
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.